In vitro and clinical evaluation of TSC: a cosmetic functional ingredient with a broad spectrum of anti-aging and antioxidant activities
Isoprenylcysteine (IPC) small molecules were identified as a new class of anti-inflammatory compounds over 20 years ago. Since then, they have been developed as novel cosmetic functional ingredients (CFI) and topical drug candidates. TSC is a second generation CFI that has previously been shown to provide a broad spectrum of benefits for the skin through its anti-inflammatory and antimicrobial properties.
Objective To determine whether TSC possesses anti-aging properties in vitro and evaluate the tolerability and activity of TSC when applied topically to human subjects.
